Manganese dipyridoxal diphosphate as a new contrast medium in the MRT of benign and malignant pancreatic tumors: initial clinical findings. MnDPDP is a new intracellular contrast medium of which 50% is excreted through the bile its acceptability and effect on MR images was studied in 21 patients, 18 of whom had malignant and three benign tumours of the pancreas. Spin echo T1 images (SE-T1: TR = 500 ms